成年小鼠作为早发性B族链球菌病的模型。
Adult mice as a model for early onset group B streptococcal disease.
作者信息
Wennerstrom D E, Schutt R W
出版信息
Infect Immun. 1978 Feb;19(2):741-4. doi: 10.1128/iai.19.2.741-744.1978.
Abstract
The intravenous inoculation of adult mice with virulent group B streptococci serotype Ia resulted in fulminating sepsis with extensive colonization of the lungs and kidneys. The time course of the infection lasting 24 to 40 h, extensive pulmonary colonization, and resistance of the type Ia organism to phagocytosis in the absence of specific antibody suggest that mice are an appropriate model for the study of early onset streptococcal infection of human neonates.
摘要
用毒力强的B族血清型Ia链球菌对成年小鼠进行静脉接种，可导致暴发性败血症，并在肺和肾中广泛定植。感染病程持续24至40小时，肺部广泛定植，且在缺乏特异性抗体的情况下Ia型菌株具有抗吞噬作用，这表明小鼠是研究人类新生儿早发性链球菌感染的合适模型。
相似文献
1
Adult mice as a model for early onset group B streptococcal disease.
Infect Immun. 1978 Feb;19(2):741-4. doi: 10.1128/iai.19.2.741-744.1978.
2
The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats.
J Infect Dis. 1992 Feb;165(2):306-14. doi: 10.1093/infdis/165.2.306.
3
Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungs.
Infect Immun. 1979 Oct;26(1):287-93. doi: 10.1128/iai.26.1.287-293.1979.
4
Virulence of human and bovine isolates of group B streptococci (types Ia and III) in experimental pregnant mouse models.
Infect Immun. 1985 Jan;47(1):94-7. doi: 10.1128/iai.47.1.94-97.1985.
5
Experimental infection with group B streptococci in tissue cages implanted in rabbits.
Zentralbl Bakteriol Mikrobiol Hyg A. 1984 Dec;258(2-3):242-55. doi: 10.1016/s0176-6724(84)80042-5.
6
Cytokine response to group B streptococcus infection in mice.
Scand J Immunol. 1998 Apr;47(4):314-23. doi: 10.1046/j.1365-3083.1998.00305.x.
7
Glutathione Synthesis Contributes to Virulence of in a Murine Model of Sepsis.
J Bacteriol. 2019 Sep 20;201(20). doi: 10.1128/JB.00367-19. Print 2019 Oct 15.
8
Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci.
Infect Immun. 1983 Aug;41(2):618-23. doi: 10.1128/iai.41.2.618-623.1983.
9
Group B streptococci. Role of capsular polysaccharide on virulence and induction of septic arthritis.
Adv Exp Med Biol. 1997;418:817-8.
10
Type III group B streptococcal infections in mice: bacteremia and meningitis following oral inoculation.
Can J Microbiol. 1981 Nov;27(11):1150-5. doi: 10.1139/m81-180.
引用本文的文献
1
Group B vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.
F1000Res. 2016 Sep 22;5:2355. doi: 10.12688/f1000research.9363.1. eCollection 2016.
2
Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.
Infect Immun. 2002 Nov;70(11):6409-15. doi: 10.1128/IAI.70.11.6409-6415.2002.
3
Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.
Infect Immun. 2000 Apr;68(4):2053-60. doi: 10.1128/IAI.68.4.2053-2060.2000.
4
Bactericidal capacity of newborn phagocytes against group B beta-hemolytic streptococci.
Infect Immun. 1981 Nov;34(2):535-9. doi: 10.1128/iai.34.2.535-539.1981.
5
Effects of route and time of administration of antiserum on protection of mice from lethal infection due to group B Streptococcus type III.
Infect Immun. 1981 Jan;31(1):391-5. doi: 10.1128/iai.31.1.391-395.1981.
6
Murine resistance to type III group B streptococci.
Infection. 1980;8(2):54-7. doi: 10.1007/BF01639146.
7
Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes.
Infect Immun. 1980 Mar;27(3):1023-32. doi: 10.1128/iai.27.3.1023-1032.1980.
8
Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci.
Infect Immun. 1983 Aug;41(2):618-23. doi: 10.1128/iai.41.2.618-623.1983.
9
Mouse protection assay for group B streptococcus type III.
Infect Immun. 1982 Jan;35(1):240-7. doi: 10.1128/iai.35.1.240-247.1982.
10
Mucin model for group B type III streptococcal infection in mice.
Infect Immun. 1980 Feb;27(2):449-54. doi: 10.1128/iai.27.2.449-454.1980.
本文引用的文献
1
Group B streptococcal neonatal and infant infections.
J Pediatr. 1973 Apr;82(4):707-18. doi: 10.1016/s0022-3476(73)80604-3.
2
Opsonin system of the group B streptococcus.
Infect Immun. 1974 Dec;10(6):1315-20. doi: 10.1128/iai.10.6.1315-1320.1974.
3
Cellular and humoral immune response to group B streptococci.
J Pediatr. 1973 Dec;83(6):926-32. doi: 10.1016/s0022-3476(73)80525-6.
4
A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newborn.
N Engl J Med. 1976 Jan 8;294(2):65-70. doi: 10.1056/NEJM197601082940201.
5
Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.
J Exp Med. 1975 Jul 1;142(1):165-79. doi: 10.1084/jem.142.1.165.
6
The effect of two isomeric octadecenoic acids on the lipid metabolism and growth of Novikoff hepatoma cells.
Biochim Biophys Acta. 1976 Jun 22;431(3):469-80. doi: 10.1016/0005-2760(76)90213-7.
7
Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease.
J Infect Dis. 1976 Apr;133(4):430-5. doi: 10.1093/infdis/133.4.430.
Zotero 插件